Predictive value of monocyte to HCL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease

被引:3
作者
Wang, Jia-Ran [1 ]
Zhao, Hai-Zhao [1 ]
Chang, Lu-Jie [1 ]
Xu, Xue [1 ]
Gao, Yuan [1 ]
Li, Meng [1 ]
Kong, Qing-Yu [1 ]
Wang, Min-Min [1 ]
Zhao, Cui-Fen [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Pediat, 107 St,Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
关键词
Monocyte to HCL-C ratio; Kawasaki disease; Prediction; Coronary artery lesions; Immunoglobulin resistance; LIPOPROTEIN-CHOLESTEROL RATIO; DENSITY; MORTALITY;
D O I
10.1007/s00431-023-05122-w
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We aimed to investigate the predictive validity of monocyte to high-density lipoprotein cholesterol ratio (MHR) for coronary artery lesions (CALs) and intravenous immunoglobulin (IVIG) resistance in complete Kawasaki disease (KD). MHR values of a total of 207 complete KD patients were calculated and analyzed with regard to their clinical characteristics and outcomes. We compared the differences in clinical data and laboratory parameters between CAL+ group and CAL- group as well as between IVIG-resistant group and IVIG-responsive group. Spearman's correlation analysis was applied to evaluate the correlation between C-reactive protein (CRP) and MHR. Multivariate logistic regression was used to identify risk factors of CALs and IVIG resistance. Receiver operating characteristic (ROC) curve analysis was chosen to determine the optimal cut-off value of MHR and its validity in predicting CALs and IVIG resistance. The MHR level was significantly higher in the CAL+ group, with cut-off value of 1.30 g/L, yielding a sensitivity of 0.753 and specificity of 0.805, as well as in IVIG-resistant group, with cut-off value of 1.03 g/L, yielding a sensitivity of 0.97 and specificity of 0.485. Multivariate logistic regression showed that MHR was an independent risk factor for CALs but not for IVIG resistance. According to the Spearman's correlation analysis, CRP was positively correlated with the MHR.Conclusions: As a practical, cost-effective inflammatory biomarker, MHR has a significantly predictive value in complete KD children complicated with CALs and IVIG-resistance. Paying more attention to the changes of MHR in KD children may contribute to better understanding of KD development and prognosis in clinical practice.
引用
收藏
页码:4399 / 4406
页数:8
相关论文
共 27 条
  • [1] Elevated Monocyte to High-Density Lipoprotein Cholesterol Ratio and Endothelial Dysfunction in Behcet Disease
    Acikgoz, Nusret
    Kurtoglu, Ertugrul
    Yagmur, Julide
    Kapicioglu, Yelda
    Cansel, Mehmet
    Ermis, Necip
    [J]. ANGIOLOGY, 2018, 69 (01) : 65 - 70
  • [2] Relationship between Serum Albumin Level and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Saphenous Vein Graft Disease in Coronary Bypass
    Akboga, Mehmet Kadri
    Yayla, Cagri
    Balci, Kevser Gulcihan
    Ozeke, Ozcan
    Maden, Orhan
    Kisacik, Halil
    Temizhan, Ahmet
    Aydogdu, Sinan
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2017, 65 (04) : 315 - 321
  • [3] The ratio of monocyte frequency to HDL cholesterol level as a predictor of asymptomatic organ damage in patients with primary hypertension
    Aydin, Emel
    Ates, Ihsan
    Arikan, Mehmet Fettah
    Yilmaz, Nisbet
    Dede, Fatih
    [J]. HYPERTENSION RESEARCH, 2017, 40 (08) : 758 - 764
  • [4] Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients
    Bolayir, Asli
    Gokce, Seyda Figul
    Cigdem, Burhanettin
    Bolayir, Hasan Ata
    Yildiz, Ozlem Kayim
    Bolayir, Ertugrul
    Topaktas, Suat Ahmet
    [J]. NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2018, 52 (02) : 150 - 155
  • [5] Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size
    Cagli, Kumral
    Tok, Derya
    Turak, Osman
    Gunertem, Eren
    Yayla, Cagri
    Lafci, Gokhan
    Ulas, Mahmut Mustafa
    Cagli, Kerim
    [J]. BIOMARKERS IN MEDICINE, 2016, 10 (10) : 1039 - 1047
  • [6] Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases
    Ganjali, Shiva
    Gotto, Antonio M., Jr.
    Ruscica, Massimiliano
    Atkin, Stephen L.
    Butler, Alexandra E.
    Banach, Maciej
    Sahebkar, Amirhossein
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (12) : 9237 - 9246
  • [7] Monocytes as a diagnostic marker of cardiovascular diseases
    Gratchev, Alexei
    Sobenin, Igor
    Orekhov, Alexander
    Kzhyshkowska, Julia
    [J]. IMMUNOBIOLOGY, 2012, 217 (05) : 476 - 482
  • [8] Kawasaki disease: a matter of innate immunity
    Hara, T.
    Nakashima, Y.
    Sakai, Y.
    Nishio, H.
    Motomura, Y.
    Yamasaki, S.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 186 (02) : 134 - 143
  • [9] Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease
    Kanbay, Mehmet
    Solak, Yalcin
    Unal, Hilmi Umut
    Kurt, Yasemin Gulcan
    Gok, Mahmut
    Cetinkaya, Hakki
    Karaman, Murat
    Oguz, Yusuf
    Eyileten, Tayfun
    Vural, Abdulgaffar
    Covic, Adrian
    Goldsmith, David
    Turak, Osman
    Yilmaz, Mahmut Ilker
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (08) : 1619 - 1625
  • [10] Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
    McCrindle, Brian W.
    Rowley, Anne H.
    Newburger, Jane W.
    Burns, Jane C.
    Bolger, Anne F.
    Gewitz, Michael
    Baker, Annette L.
    Jackson, Mary Anne
    Takahashi, Masato
    Shah, Pinak B.
    Kobayashi, Tohru
    Wu, Mei-Hwan
    Saji, Tsutomu T.
    Pahl, Elfriede
    [J]. CIRCULATION, 2017, 135 (17) : E927 - E999